ABEONA THERAPEUTICS INC. (ABEO)

5.92USD -1.99% (-0.12)

Over 1M: -7.8%

Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

6 6.5 7 7.5
31 Jul 5 Aug 10 Aug 13 Aug 18 Aug 21 Aug 26 Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '21 — Operating Income: -14.9M Q3 '21 — Free Cash Flow: -10.7M Q4 '21 — Operating Income: -46.7M Q4 '21 — Free Cash Flow: -33.5M Q1 '22 — Operating Income: -20.6M Q1 '22 — Free Cash Flow: -13.8M Q2 '22 — Operating Income: -8M Q2 '22 — Free Cash Flow: -9M Q3 '22 — Operating Income: -9.4M Q3 '22 — Free Cash Flow: -6.8M Q4 '22 — Operating Income: -12.9M Q4 '22 — Free Cash Flow: -14M Q1 '23 — Operating Income: -12M Q1 '23 — Free Cash Flow: -12M Q2 '23 — Operating Income: -10.6M Q2 '23 — Free Cash Flow: -10.3M Q3 '23 — Operating Income: -11.3M Q3 '23 — Free Cash Flow: -5.8M Q4 '23 — Operating Income: -13.2M Q4 '23 — Free Cash Flow: -9.3M Q1 '24 — Operating Income: -14.3M Q1 '24 — Free Cash Flow: -15.3M Q2 '24 — Operating Income: -17.9M Q2 '24 — Free Cash Flow: -13.4M Q3 '24 — Operating Income: -15.3M Q3 '24 — Free Cash Flow: -12.6M Q4 '24 — Operating Income: -16.7M Q4 '24 — Free Cash Flow: -17.2M Q1 '25 — Operating Income: -19.7M Q1 '25 — Free Cash Flow: -19.8M Q2 '25 — Operating Income: -22.8M Q2 '25 — Free Cash Flow: -21.7M Q3 '25 — Operating Income: -24M Q3 '25 — Free Cash Flow: -23.7M Q4 '25 — Operating Income: -22.9M Q4 '25 — Free Cash Flow: -19.1M Q1 '26 — Operating Income: -23M Q1 '26 — Free Cash Flow: -20.7M Q2 '26 — Operating Income: -13.7M Q2 '26 — Free Cash Flow: -18M -40M -30M -20M -10M 0
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Operating Income Free Cash Flow

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 62 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

0.6
SBC / sales 45.4%
OE margin -364.8%
Oper. margin -327.6%
ROIC -691.5%
Gross margin 67.1%
Accruals 7.6%
EBITDA margin -316.6%
FCF margin -319.5%
OCF margin -299.5%
Profit margin -246.4%
ROA -35.0%
ROCE -54.0%
ROE -49.1%
OCF / EBIT —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

3.5
EV/Sales 8.5×
EV/OE -2.3×
P/C 2.3×
P/B 2.6×
FCF yield -24.3%
Div. yield —
EV/EBIT —
EV/GP —
Fwd P/E —
P/E —
PEG —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

1.0
RPO growth 0.0%
RPO / sales —
Segment HHI —

2 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.8
ND/EBITDA 0.55
Interest cover -25.3×
Cash / Debt 5.2×
Debt payback 0.0 yr
Quick ratio 6.4×
Debt / Eq 0.22×
Cash runway 1.5 yr
F-score 3.9 pts
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

4.0
Sales CAGR 4Y -10.3%
Sales Q/Q +2745.0%
EPS Y/Y -168.2%
Shares change +61.2%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS next Y —
Sales/sh Y/Y —

3 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.